Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Post-transplantation Diabetes Mellitus

NCT03157414 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03157414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03157414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Post-transplantation Diabetes Mellitus
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 7, 2016
Completion date
June 28, 2018
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, renal insufficiency, safety issues